Literature DB >> 31359153

An adolescent with lupus nephritis presenting with fever, lymphadenomegaly, and arthralgia: Answers.

Gizem Yildiz1, Meral Torun Bayram2, Alper Soylu2, Salih Kavukçu2.   

Abstract

Entities:  

Keywords:  Acute inflammatory syndrome; Arthralgia; Fever; Lymphadenomegaly; Mycophenolate mofetil; Systemic lupus erythematosus

Year:  2019        PMID： 31359153     DOI： 10.1007/s00467-019-04308-5

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  13 in total

1.  Acute inflammatory syndrome with elevated procalcitonin induced by mycophenolate sodium.

Authors:  Jan Loock; Peter Lamprecht; Wolfgang L Gross
Journal:  J Rheumatol       Date:  2012-03       Impact factor: 4.666

2.  Acute inflammatory syndrome following introduction of mycophenolate mofetil in a patient with systemic lupus erythematosus.

Authors:  Irina Konon; Mary E Cronin; Lawrence M Ryan
Journal:  Arthritis Rheum       Date:  2008-05-15

Review 3.  Autoimmune and medication-induced lymphadenopathies.

Authors:  Alejandro A Gru; Dennis P O'Malley
Journal:  Semin Diagn Pathol       Date:  2017-11-28       Impact factor: 3.464

Review 4.  Acute Inflammatory Syndrome Paradoxically Induced by De Novo Purine Inhibitors Synthesis Before Renal Transplantation: A Case Report and Review of the Literature.

Authors:  Y Maruyama; T Sadahira; Y Mitsui; K Wada; R Tanimoto; S Nishimura; Y Kobayashi; T Watanabe; Y Nasu; M Araki
Journal:  Transplant Proc       Date:  2018-03-21       Impact factor: 1.066

5.  Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial.

Authors:  Rachel B Jones; Thomas F Hiemstra; Jose Ballarin; Daniel Engelbert Blockmans; Paul Brogan; Annette Bruchfeld; Maria C Cid; Karen Dahlsveen; Janak de Zoysa; Georgína Espigol-Frigolé; Peter Lanyon; Chen Au Peh; Vladimir Tesar; Augusto Vaglio; Michael Walsh; Dorothy Walsh; Giles Walters; Lorraine Harper; David Jayne
Journal:  Ann Rheum Dis       Date:  2019-01-05       Impact factor: 19.103

6.  Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups.

Authors:  P Halloran; T Mathew; S Tomlanovich; C Groth; L Hooftman; C Barker
Journal:  Transplantation       Date:  1997-01-15       Impact factor: 4.939

7.  Mycophenolate mofetil for sustained remission in nephrotic syndrome.

Authors:  Uwe Querfeld; Lutz T Weber
Journal:  Pediatr Nephrol       Date:  2018-05-11       Impact factor: 3.714

Review 8.  Mycophenolate mofetil: An update.

Authors:  Maria Cristina Villarroel; Manuel Hidalgo; Antonio Jimeno
Journal:  Drugs Today (Barc)       Date:  2009-07       Impact factor: 2.245

9.  Acute inflammatory syndrome induced by mycophenolate mofetil in a patient following kidney transplantation.

Authors:  K Hochegger; J Gruber; K Lhotta
Journal:  Am J Transplant       Date:  2006-04       Impact factor: 8.086

10.  Systemic lupus erythematosus and granulomatous lymphadenopathy.

Authors:  Devendra Shrestha; Ajaya Kumar Dhakal; Raj K C Shiva; Arati Shakya; Subhash Chandra Shah; Henish Shakya
Journal:  BMC Pediatr       Date:  2013-11-05       Impact factor: 2.125
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.